Background and Objective: Polycystic ovary syndrome (PCOS) is a common heteroge-
| INTRODUCTION
Polycystic ovarian syndrome (PCOS) is one of the most common heterogeneous endocrine disorders that influence 7%-15% of women of reproductive age. It is characterized by chronic oligo-anovulation, clinical or biochemical signs of hyperandrogenism, not related to other causes of hyperanderogenism and polycystic ovaries morphology, based on the results of pelvic ultrasound.
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The aetiology of PCOS is not completely understood, but recent evidence suggests that insulin resistance with compensatory hyperinsulinaemia and hyperandrogenism contribute to the stimulation of ovarian androgen secretion and inhibition of hepatic sex hormone-binding globulin production. Dysfunction of adipose tissues has been identified as a contributor factor to insulin resistance observed in PCOS. In addition, environmental and genetic factors also play some roles in the development of PCOS. 2 The dysmetabolic aspect of PCOS has gained more attention in recent decades. Several features of metabolic disturbances, insulin resistance and hyperinsulinaemia particularly have been observed in most women with PCOS. 3 Therefore, obesity and visceral obesity are very common among women with PCOS, which is associated with metabolic syndrome (MetS). 4 MetS is a cluster of endocrinopathy and metabolic disturbances including hyperglycaemia/ insulin resistance, central obesity, dyslipidaemia and hypertension. 5 In this respect, some studies report that MetS is more common among women with PCOS due to the higher prevalence of insulin resistance, obesity and visceral obesity in these patients. 6, 7 The hypothesis developed that women with PCOS also have an elevated MetS risk is further confirmed by a meta-analysis, indicating that women with PCOS have an elevated prevalence of MetS in both body mass index (BMI) and non-BMI matched samples. 7 Recent evidence suggests that some confounding factors, including the study method and some anthropometrics characteristics including age and BMI, seriously affect results. 8, 9 However, the aim of this systematic review and meta-analysis was to provide a more realistic estimate risk of MetS in women with and without PCOS and to assess the effect of the study method and potential confounding factors on the risk of MetS in women with PCOS.
| METHODS
This systematic review and meta-analysis was designed according to the referred reporting items for systematic reviews and meta-analyses of the PRISMA statement 10 to assess the following outcomes:
1. The odds of MetS among women with PCOS compared to healthy controls with and without age and/or BMI matching/ adjustments 2. The odds of MetS among women with PCOS compared to healthy controls in various subgroups of age
The odds of MetS among women with PCOS compared to healthy
controls in various subgroups of study methods
4.
The odds of MetS among women with PCOS compared to healthy controls in various subgroups of age and study methods.
| Search strategy
A comprehensive literature search was performed in PubMed [includ-
ing Medline], Web of Science and Scopus databases for retrieving articles in English language on the prevalence/incidence and odds of metabolic syndrome in women with PCOS, compared to healthy controls. Further, a manual search in the references list of studies included and other relevant reviews were used to maximize the identification of eligible studies.
The following MeSH terms keywords, alone or in combination,
were used for the search: "Polycystic Ovary Syndrome" OR "Polycystic
Ovarian Syndrome" OR "polycystic ovary disease" OR "polycystic ovaries," OR "polycystic ovarian morphology" OR "PCOS" OR "PCOD" OR "PCO" OR "PCOM" OR "Stein Leventhal Syndrome" AND "Metabolic
Syndrome" OR "X syndrome."
The screening of titles, abstracts and full-text articles was conducted independently by the authors for determining final eligibility criteria. Disagreements were resolved through discussions.
| Selection criteria and data extraction
In this meta-analysis, articles that compared the prevalence of MetS between reproductive age women with PCOS and healthy controls without PCOS were included.
The general characteristics of the studies including "the first author name, journal, publication year, design, recruitment source, ethnicity, sample size for cases and controls," PCOS and control groups' characteristics including "selection methods, age and BMI," "PCOS/ MetS definition and study method quality" and "prevalence of MetS with and without adjustments, odds ratios with confidence intervals with and without adjustments or matching" were extracted from the studies included and assessed.
| Quality assessment
All included studies for this meta-analysis were critically apprised using the modification of the Newcastle-Ottawa Quality Assessment Scale for nonrandomized studies (NOS). 11 The NOS evaluated the quality of published nonrandomized studies in terms of selection, comparability and outcome. Studies with a score above 5 were considered high quality.
| Statistical analysis
The Software package stata (version 12; STATA Inc., College Station, TX, USA) was used to conduct statistical analysis. Heterogeneity between studies was assessed using Chi square statistics, and P > .05
was interpreted as homogeneity. Some significant heterogeneity in some of the analyses was reported in meta-analysis. Heterogeneous and nonheterogeneous results were analyzed using the fixed effect and random-effects inverse variance model for calculating the pooled effect. Also, the subgroup analyses were also prespecified, based on age groups ("adolescent," "adult" and "reproductive age adults and adolescents"), different methods of controlling confounders such as age and BMI ("without controlling confounders," "age matching/adjustment," "BMI matching/adjustment," and in the complete model of "age and BMI matching/adjustment") to present the most realistic association between PCOS and MetS. The publication bias was estimated using the Begg's test and/or Egger's test using a significance level of P < .05 to indicate significant asymmetry. Trim and fill's method of bias adjusting was used in case of significant publication bias test results and for correcting it.
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The primary pooled effect analysis estimated the weighted of the odds of MetS among study groups as odds ratio [OR, 95% confidence interval (CI)] based on the Mantel-Haenszel method for meta-analysis.
Some studies reported the prevalence of MetS in different phenotypes of PCOS. 8, [13] [14] [15] [16] In such cases, we calculated the total weighted prevalence of PCOS among the total population of PCOS, using the Wolf method. 17 If (OR and/or CI) for MetS was missing from the study report, 8, 9, [13] [14] [15] it was calculated from the prevalence based on the formulae set out in the Fundamentals of Biostatistics Book.
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| RESULTS
The search strategy yielded 2759 potentially relevant articles. A flow chart of literature search and its results were reported in Figure 1 .
According to the selection criteria, 107 articles were identified for further full-text assessment. Finally, 44 full-text articles were included for the meta-analysis. It should be noted that some studies used various PCOS/MetS diagnostic criteria or different age groups with various methods of confounder control; in these studies, each one was included in the meta-analysis as a separate data. Total number of studies groups included in meta-analysis (n = 44) National Heart Lung Blood Institute (AHA) and its modification criteria. 62 Four articles 20, 21, 23, 43 
| Study characteristics
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Two articles, however, did not introduce the specific MetS criteria 13, 44 and thirteen articles 13, 15, [20] [21] [22] 24, 33, 35, 39, 40, 43, 49, 54 used multiple definitions in the same data set.
In addition, different age groups were used in the articles; 21 and other for age and race 13 using matching.
All articles reported the prevalence of MetS in PCOS except one that was a cohort study and reported MetS incidence in PCOS.
25 Table 1 presents the summary of studies assessing MetS prevalence in women with and without PCOS. Table 3 shows the summary of pooled OR of MetS and its heterogeneity and publication bias estimation among various subgroups of women with PCOS, compared to healthy controls.
| Meta-analysis of odds ratio of MetS among women with PCOS vs healthy controls
| Total of studies
A total of 72 articles including 18 529 women with PCOS and 15 891 healthy controls entered the OR meta-analysis. There were significant heterogeneities (χ 2 = 1257, P = .001) and publication bias between the studies (Egger's test = 0.001 and Begg's test = 0.001). Therefore, the random effect model with Trim and Fill correction was used for analysis. In this respect, the odds ratio of MetS in PCOS was 2.5 fold higher than in healthy controls (Pooled Overall OR totally = 2.5, 95% CI: 2.0-3.2) (Fig. S1 ). The results of subgroup analysis in different age groups with age and BMI matching/ adjustment are presented below. The results of other models for controlling confounders are showed in Table 3 .
Adolescents with age and BMI matching/adjustment:
A total of 4 studies involving 204 adolescents with PCOS and 537 adolescent healthy controls entered the meta-analysis. There were no heterogeneities (χ 2 = 0.74, P = .86) and publication bias (Egger's test = 0.78 and Begg's test = 0.50) among these studies. In this respect, the odds of MetS among adolescents with PCOS was 6.1 fold higher than that among adolescent healthy controls (Pooled Overall OR for adolescent overall = 6.1, 95% CI: 5.5-6.1) (Fig. S2 ). 
Adults with age and BMI matching
| Population-based studies
A total of 10 studies including 788 women with PCOS and 3219 healthy controls entered in the OR meta-analysis of populationbased studies. There was significant heterogeneity (χ 2 = 66, P = .001) without publication bias (Egger's test = 0.34 and Begg's test = 0.65) between all population-based studies included. In this respect, the pooled odd ratio of MetS in PCOS was 2.1 fold higher than in healthy controls (Pooled Overall OR population-based studies overall = 2.1, 95% CI: 1.2-3.9) (Fig. S5 ). However, there were limited data for meta-analysis between various subgroups studies with different forms of confounder control. Here, we present the results of meta-analysis based on age groups. The results of other models for control of confounders are shown in Table 3 . 
Adults and adolescents:
A total of 4 articles involving 140 reproductive age women with PCOS and 296 healthy controls entered the meta-analysis. There was significant heterogeneity (χ 2 = 8, P = .05) with publication bias (Egger's test = 0.03 and Begg's test = 0.50) among them. In this respect, there were no statistically significant differences between PCOS and controls were reported (Pooled Overall OR for adult and adolescent in population-based studies overall = 2, 95% CI: 0.9-4.5). In this respect, the odd ratio of MetS in PCOS was 2.6 fold higher than in healthy controls (Pooled Overall OR for nonPopulation-based studies overall = 2.6, 95% CI: 2.0-3.3) (Fig. S6) . The results of subgroup analysis for different age groups and control of age and BMI with matching/ adjustment were presented as below. The results of other models for controlling confounders are showed in Table 3 .
| Nonpopulation-based studies
Adolescents with age and BMI matching/adjustment:
As we did not have population-based studies in this subgroup, the results of nonpopulation-based studies are similar to those of all studies in this subgroup. In addition, subgroup analysis was performed based on diagnostic criteria of PCOS. Results are presented in Table S1 , Fig. S1 . The OR of MetS in PCOS using, NIH was higher than AES and Rotterdam (Pooled Overall OR based on NIH criteria = 6.05, 95% CIL: 6.0-6.04). The OR (95% CI) was calculated.
Adults with age and BMI matching/adjustment:
| DISCUSSION
T A B L E 1 (Continued)
T A B L E 2 Quality assessment of included studies using the Newcastle-Ottawa Quality Assessment Scale for nonrandomized studies Amato et al. Aydin et al. Caliskan et al. Coviello et al. Cussons et al. Gambineri et al. Glueck et al. Gulcelik et al. Hahn et al. Hart et al. Hillman et al. Hosseinpanah et al. Hudecova et al. Lankarani et al. Leibel et al. Roe et al. Romanowski et al. Shroff et al. Vrbíková et al. Vrbíková et al. Vural et al. Welt et al. Ziaee et al. T A B L E 3 Results of heterogeneity and publication bias estimation a and subgroup meta-analysis for various study population, design and control of confounders among polycystic ovary syndrome (PCOS) vs controls In this respect, the subgroup analysis among different age groups with the complete model of both age and BMI adjustment/matching showed that the odds of MetS in adolescents with PCOS was six fold higher than their healthy counterparts, whereas the odds of MetS in adults with PCOS was 2.6 compared to healthy controls.
As such, subgroup meta-analysis was performed among populationbased studies, which confirmed the result of meta-analysis among adolescents. In this respect, increased odds of MetS was found among adolescents in population-based studies compared to their healthy counterparts, although no statistically significant differences between the odds of MetS among adults with PCOS compared to controls were reported.
In line with this study, Moran et al 7 in a meta-analysis of 18 studies reported that women with PCOS had the increased prevalence of MetS overall (OR 2.88, 95% CI: 2.40, 3.45) and in the BMI-matched subjects group (OR 2.20, 95% CI: 1.36, 3.56); however, the participants of studies included in this meta-analysis were of different age groups of adults and adolescents. In addition, some of the studies had population-based designs, which were not assessed separately.
However, the higher odds of MetS among adolescents with PCOS could be attributed to the higher prevalence of cardio-metabolic risk factors, including insulin resistance/dysglycaemia due to pancreaticβ-cell dysfunction, hypertension and dyslipidaemia in PCOS than in non-PCOS adolescents independent of, but worsened by obesity and central obesity.
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In addition, the higher odds of MetS in adolescents than in adults may be due to stricter diagnostic criteria for PCOS in adolescents than in adults. In this respect, anovulation, hyperandrogenism and physiologic insulin resistance are prevalent among young girls, although polycystic ovary morphology is a fair common finding during puberty. 70 74 In this regard, production of androgen may be reduced due to limited adrenal secretion and ovarian ageing across time. 75 Consequently, the prevalence androgen-dependent complications such as hirsutism, acne and glucose intolerance decreases with age. 76 While it is expected that ageing increase the risk of insulin resistance and metabolic disturbances, the improvement of MetS among adult women with PCOS in this study may be mainly attributed to modifications in life style, such as weight loss among women with PCOS and weight gain among non-PCOS women. 77 It is suggested that if BMI and waist circumference could be controlled appropriately, younger hyperandrogenic women with PCOS might decrease the risk of MetS later in life. 75 The results of this meta-analysis show that the method of sample recruitment could seriously affect the estimation MetS prevalence among women with PCOS and healthy controls. In this respect, in population-based studies, the odds of MetS did not differ among adults with PCOS compared to healthy controls. We hypothesized that samples of population-based studies were representative of PCOS population including older, lower BMI women with milder phenotypes that show the real feature of this syndrome; however, clinical-based studies commonly present the results of severe phenotypes of PCOS referred for treatment, which may be misleading.
However, these results were not supported by age-matched subgroups analysis for population-based studies, which showed the higher odds of MetS in adults with PCOS, which may be due to this result from an Australian population-based study which used different a Trim and Fill adjusted results in case of significant publication bias. b In the case of using various PCOS/MetS diagnostic criteria, age group and method of confounder's control among the same data set, each one was included in the meta-analysis as a separate data.
T A B L E 3 (Continued)
Subgroup analysis based on PCOS diagnostic criteria showed that hyperandrogenism is an important component of this disorder.
The limitations of thisstudy that need to be addressed. The overall number of high-quality studies was limited; in addition, the limited number of population-based studies did not allow us to perform metaanalysis among various subgroups. There was also the concern that the results of one study might have a great effect on the results of the meta-analysis, which emphasizes the need for caution in interpretation of findings. Also, 13 studies included reproductive age women without any separation between adults and adolescents in their investigation;
as characteristics of PCOS in adolescents and adults with PCOS differ, we speculate that the results were not conclusive. In addition, the literature varies with different ethnicity and diagnostic criteria for PCOS and MetS. However, many studies defined PCOS and MetS based on ESHRE/ASRM and ATP III diagnostic criteria.
Despite efforts for maintaining the possible biases in this metaanalysis, there may also be selection bias in some subgroups, to minimize selection bias, study selection was conducted based on the eligibility criteria, determined before the study. A manual search on the reference lists of all selected papers was also conducted to prevent missing studies.
In conclusion, this meta-analysis demonstrated that adolescents with PCOS had an increased odds of MetS, compared to healthy adolescent controls, results not supported by differences among adults with PCOS, compared to the general population, a finding that could present the most reliable feature of this syndrome and help clarify some conflicting data.
